Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferumoxytol vs Oral Iron in CKD Anemia
NCT00255437Phase 3Completed
- Sponsor
- AMAG Pharmaceuticals, Inc.
- Start
- Jun 2004
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ferumoxytol in anemia of chronic kidney disease (CKD-A), sponsored by AMAG Pharmaceuticals, Inc.. Started Jun 2004; status: completed.
02
Drugs
ferumoxytol
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT00255437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00255437.